Composition : Amoxycillin (400mg) + Clavulanic Acid (57mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹0/-
Please Contact For Best Price
Moxyplit CV 457 Tablet (Amoxycillin 400 mg + Clavulanic acid 57 mg DT) is a highly effective, beta-lactamase inhibitor-protected antibiotic. The combination ensures Amoxycillin remains active against bacteria that have developed resistance. The Dispersible Tablet (DT) form is crucial for high patient compliance, especially in pediatric and geriatric care, making it a market powerhouse.
Key Commercial Value & Clinical Edge:
-
Resistance Coverage Clavulanic acid provides a crucial clinical edge against resistant bacterial strains, guaranteeing prescription by specialists when first-line antibiotics fail.
-
Dispersible Technology (DT) The DT formulation offers superior patient convenience (no swallowing issues) and faster absorption, securing its premium positioning in the pediatric and high-compliance segments.
-
Broad Spectrum Use This combination is the gold standard for treating severe respiratory tract infections (RTIs), complicated ear, nose, throat (ENT) infections, and skin/soft tissue infections.
-
Specialist Demand The product is heavily prescribed by Pediatricians, General Physicians, and Pulmonologists, ensuring robust, high-volume sales across primary and secondary healthcare markets.
Secure your exclusive Moxyplit CV 457 territory and capitalize on the premium, resistance-fighting antibiotic market!
Read More